IDEX Corporation
IEXBusiness Overview
source: coverage-next-full ticker: IEX step: "01" title: Business Overview — IDEX Corporation created: 2026-05-29
Step 01: Business Overview — IDEX Corporation
Company Snapshot
IDEX Corporation is a diversified industrial manufacturer headquartered in Lake Forest, Illinois. Founded in 1987 and listed on the NYSE, IDEX has grown from a small pump manufacturer into a $16B+ enterprise through a combination of organic expansion and disciplined bolt-on acquisitions. The company's core competency is engineering highly specialized fluid-handling, metering, and related flow-control products for demanding applications where failure is not an option — water treatment, pharmaceutical manufacturing, fire suppression, semiconductor fabrication, and more.
The IDEX operating model is distinctive: the company operates as a portfolio of decentralized entrepreneurial businesses ("80/20 businesses"), each serving niche markets with specialized, low-volume, high-value products. This structure minimizes commoditization risk and sustains pricing power. The corporate center provides capital allocation discipline, operational frameworks (the IDEX Business System, or IBS), and shared services, while individual business units retain P&L accountability and customer intimacy.
Segment Overview
1. Fluid & Metering Technologies (FMT) — ~38% of Revenue
FMT is IDEX's original core business, encompassing pumps, meters, and flow-control equipment for industrial and municipal water applications. Key brands include:
- Pulsafeeder — chemical metering pumps for water/wastewater treatment
- Colfax Fluid Handling (Lutz-JESCO, Warren Rupp) — various industrial pump types
- CIRCOR Flow Technologies (acquired brands) — precision flow control
- Banjo — plastic fittings and valves for agricultural applications
- Toptech — terminal automation and fuel management systems
FMT products typically serve water/wastewater infrastructure, oil & gas downstream, chemical processing, and agriculture. Customer demand is driven by municipal capex cycles, chemical plant expansions, and agricultural seasons. Aftermarket parts and service represent a meaningful (30–40%) revenue component, providing recurring revenue.
2. Health & Science Technologies (HST) — ~38% of Revenue
HST is IDEX's highest-margin and fastest-growing segment, comprising precision fluidics components for life sciences, analytical instruments, and semiconductor equipment. Key brands include:
- IDEX Health & Science — microfluidics components (pumps, valves, tubing) for chromatography and diagnostics
- Rheodyne — HPLC (high-performance liquid chromatography) valves and components
- Semrock — optical filters for life science instruments (fluorescence microscopy, flow cytometry)
- CUI — fluid sampling and pressure measurement for analytical instruments
- Micropump — miniature magnetically-coupled gear pumps
HST customers include life science instrument OEMs (Thermo Fisher, Waters Corp, Agilent), semiconductor equipment manufacturers (Applied Materials, ASML suppliers), and diagnostics companies. The content per instrument is small but critical, and switching costs are very high due to qualification requirements.
3. Fire & Safety / Diversified Products (FSDP) — ~24% of Revenue
FSDP encompasses firefighting equipment, rescue tools, and industrial dispensing systems. Key brands include:
- Hurst Jaws of Life — hydraulic rescue tools used globally by fire departments and emergency responders
- Class 1 — electronic monitoring systems for fire trucks and emergency vehicles
- Akron Brass — nozzles, monitors, and valves for fire suppression
- Band-It — stainless steel strapping and clamping systems for industrial bundling
- Dispensing — engineered dispensing/mixing equipment for coatings and adhesives
FSDP serves municipal fire departments, industrial facilities, and specialty manufacturing. Growth is more cyclical and budget-dependent than HST, but demand is underpinned by mandated equipment replacement cycles for fire safety.
Geographic Mix (FY2023)
| Geography | Revenue Share |
|---|---|
| United States | ~55–57% |
| Europe | ~23–25% |
| Asia Pacific | ~12–14% |
| Rest of World | ~6–8% |
International revenue (~43–45% of total) creates both growth opportunity and FX translation risk. IDEX has manufacturing in the US, UK, Germany, Denmark, India, and China.
Business Model Economics
- Pricing power: IDEX products are priced on value, not cost. In many applications (pharmaceutical, semiconductor, municipal water), the pump or sensor represents <1% of total system cost but is mission-critical. This drives premium pricing and customer stickiness.
- Aftermarket: Replacement parts, service kits, and consumables generate 30–40% of segment revenues depending on the business. Aftermarket margins are structurally higher than OEM equipment margins.
- OEM relationships: Many HST and FMT products are designed into OEM equipment platforms. Once specified, displacement requires competitor qualification — a multi-year process.
- Acquisition model: IDEX acquires founder-owned or corporate-divested niche businesses at 10–14x EBITDA and improves margins via the IDEX Business System (pricing, lean manufacturing, SG&A leverage). Management targets >15% IRR on acquisitions.
Key Customers
IDEX serves thousands of customers; no single customer exceeds 10% of revenue. Key OEM relationships exist with Thermo Fisher Scientific, Agilent Technologies, Danaher (life science OEM), and large municipal water utilities. The fragmented customer base is a quality indicator.
Employees
IDEX employs approximately 10,000 people globally as of FY2023, organized across ~50 operating units.
Financial Snapshot
source: coverage-next-full ticker: IEX step: "04" title: Financial Snapshot — IDEX Corporation created: 2026-05-29
Step 04: Financial Snapshot — IDEX Corporation
Income Statement Summary (FY2021–FY2023)
| Metric | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Revenue | $2,867M | $3,261M | $3,331M |
| Gross Profit | $1,287M | $1,441M | $1,481M |
| Gross Margin | 44.9% | 44.2% | 44.5% |
| Operating Income (GAAP) | $557M | $640M | $658M |
| Operating Margin (GAAP) | 19.4% | 19.6% | 19.8% |
| Adjusted Operating Income | $690M | $798M | $816M |
| Adjusted Operating Margin | 24.1% | 24.5% | 24.5% |
| EBITDA (adjusted) | $790M | $920M | $945M |
| EBITDA Margin (adjusted) | 27.5% | 28.2% | 28.4% |
| Interest Expense | ($57M) | ($82M) | ($109M) |
| Pre-tax Income (GAAP) | $500M | $558M | $549M |
| Income Tax Expense | ($101M) | ($117M) | ($117M) |
| Effective Tax Rate | 20.2% | 21.0% | 21.3% |
| Net Income (GAAP) | $399M | $441M | $432M |
| Net Income Margin (GAAP) | 13.9% | 13.5% | 13.0% |
| Diluted EPS (GAAP) | $5.20 | $5.80 | $5.67 |
| Adjusted Diluted EPS | $6.72 | $8.16 | $8.83 |
Notes on GAAP vs. Adjusted:
- The gap between GAAP and adjusted EPS is primarily driven by amortization of acquisition intangibles (~$130–160M per year), a non-cash charge from IDEX's active M&A history
- Restructuring charges and deal costs add another $20–40M annually to the GAAP-to-adjusted bridge
- For comparability with peers and valuation purposes, adjusted metrics are the primary analytical framework
Margin Structure Analysis
| Margin | FY2021 | FY2022 | FY2023 | Trend |
|---|---|---|---|---|
| Gross Margin | 44.9% | 44.2% | 44.5% | Stable |
| Adj. EBITDA Margin | 27.5% | 28.2% | 28.4% | Improving |
| Adj. Operating Margin | 24.1% | 24.5% | 24.5% | Stable/improving |
| Net Income Margin (GAAP) | 13.9% | 13.5% | 13.0% | Declining slightly |
| FCF Margin | ~19–20% | ~19% | ~20% | Stable |
Gross margin stability (44–45%) despite commodity inflation in 2021–2022 demonstrates IDEX's pricing power. Management successfully passed through input cost increases with minimal gross margin compression.
Adjusted EBITDA margin expansion from 27.5% to 28.4% over three years reflects operating leverage, pricing contribution, and mix improvement (HST growing faster as a % of revenue until 2022).
GAAP net margin pressure is largely a function of rising interest expense (from higher debt post-acquisitions and rising rates) and higher intangible amortization — both non-operational factors.
Segment Profitability (FY2023)
| Segment | Revenue | Adj. Operating Income | Adj. Op. Margin |
|---|---|---|---|
| FMT | $1,265M | ~$355M | ~28.1% |
| HST | $1,259M | ~$305M | ~24.2% |
| FSDP | $807M | ~$205M | ~25.4% |
| Corporate/Other | — | (~$49M) | — |
| Total | $3,331M | ~$816M | ~24.5% |
FMT has the highest segment margins, reflecting its mature niche positions and high aftermarket content. HST margins were pressured in 2023 by destocking volumes (fixed cost deleverage). FSDP margins are structurally competitive with good niche market positions.
Free Cash Flow
| Metric | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Operating Cash Flow | $618M | $625M | $694M |
| Capital Expenditures | ($76M) | ($98M) | ($83M) |
| Free Cash Flow | $542M | $527M | $611M |
| FCF / Net Income (GAAP) | 136% | 119% | 141% |
| FCF / Adj. Net Income | ~84% | ~75% | ~84% |
FCF consistently exceeds GAAP net income due to the high non-cash amortization load — FCF/GAAP NI ratios of 120–140% are expected to persist. The FCF conversion vs. adjusted earnings (~80–85%) is solid for an acquisitive industrial company.
CapEx intensity is low (~2.5–3.0% of revenue), reflecting IDEX's asset-light assembly and engineering model. Most manufacturing is specialized but not capital-intensive (no large foundries or stamping plants). This low reinvestment burden is a structural FCF quality advantage.
Key Valuation Metrics (at $210/share, ~76.5M diluted shares = ~$16.1B market cap)
| Metric | Value |
|---|---|
| P/E (GAAP, FY2023) | ~37x |
| P/E (Adjusted, FY2023) | ~24x |
| EV/EBITDA (Adjusted) | ~18.5x |
| EV/Revenue | ~5.3x |
| FCF Yield (GAAP FCF) | ~3.8% |
| Dividend Yield (at $210/share) | ~1.0% |
Note: IDEX typically trades at a premium to industrial peers given its consistent margins, low cyclicality, and FCF conversion.
Historical Revenue Growth Rates
| Period | Revenue Growth |
|---|---|
| FY2019→FY2020 | +2% (COVID-resilient) |
| FY2020→FY2021 | +11% (recovery) |
| FY2021→FY2022 | +14% (cycle + pricing) |
| FY2022→FY2023 | +2% (destocking headwind) |
| 5-Year CAGR (2018–2023) | ~6–7% |
The 5-year CAGR includes organic growth of ~3–5% and M&A contribution of ~2–3%, consistent with IDEX's long-term compounding model.
Earnings Quality Assessment
IDEX's earnings quality is high:
- FCF consistently tracks or exceeds adjusted earnings
- Gross margins have been stable for 10+ years (no quality compression)
- Working capital management has improved (DSO stable, inventory turns slightly improving)
- Revenue recognition is straightforward (equipment delivery and service) — minimal deferred revenue complexity
- The primary accounting judgment involves goodwill impairment testing and intangible amortization periods, both conservative
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $IEX.